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Summary
Objective: To explore the relationships between C-reactive protein (CRP), metabolic syndrome (MetS) and incidence of severe knee or hip
osteoarthritis (OA) in a prospective study.
Methods: A population-based cohort (n¼ 5171, mean age 57.5 5.9 years) was examined between 1991 and 1994. Data was collected on
lifestyle habits, measures of overweight, blood pressure as well as high-density lipoprotein (HDL) cholesterol, triglycerides, glucose and CRP
measured with high-sensitive methods. Incidence of severe OA, deﬁned as arthroplasty due to knee or hip OA, was monitored over 12 years
of follow-up, in relation to CRP levels and presence of the MetS according to the adult treatment panel III-national cholesterol education
program (ATPIIIeNCEP) deﬁnition.
Results: A total of 120 participants had severe hipOAand 89 had kneeOAduring the follow-up. After adjustment for age, sex, smoking, physical
activity and CRP, presence of MetS was associated with signiﬁcantly increased risk of kneeOA (relative risk [RR]: 2.1, 95% conﬁdence interval
[CI]: 1.3e3.3). However, this relationship was attenuated and non-signiﬁcant after adjustment for body mass index (BMI) (RR: 1.1, 95% CI:
0.7e1.8). MetS was not signiﬁcantly associated with incidence of hip OA. In women, CRP was associated with knee OA in the age-adjusted
analysis. However, there was no signiﬁcant relationship between CRP and incidence of knee or hip OA after risk factor adjustments.
Conclusion: The increased incidence of knee OA in participants with the MetS was largely explained by increased BMI. CRP was not asso-
ciated with incidence of knee or hip OA when possible confounding factors were taken into account.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Several studies have shown that individuals with obesity or
overweight have increased risk of osteoarthritis (OA) in the
knee1e7. Although the role of obesity for the development of
OA in the hip is less clear, several large prospective popu-
lation studies have suggested that obesity also is associ-
ated with hip OA8e12. The pathogenic mechanisms
underlying this association are debated, and several hy-
potheses have been proposed13e16. There is general
agreement that biomechanics and increased dynamic load-
ing of the joint are involved, but it was suggested that other
factors associated with obesity could contribute to the in-
creased incidence of OA.
Obesity, hypertension, dyslipidemia, diabetes and insulin
resistance tend to cluster into the so-called metabolic syn-
drome (MetS)17. These risk factors are more prevalent in
patients with OA18. Elevated plasma level of C-reactive pro-
tein (CRP), a marker of low-grade systemic inﬂammation, is
another factor frequently found in obese individuals.*Address correspondence and reprint requests to: Gunnar
Engstro¨m, M.D., Ph.D., AstraZeneca R&D, 22187 Lund, Sweden.
Tel: 46-46338794; Fax: 46-46337882; E-mail: gunnar.engstrom@
astrazeneca.com
Received 17 March 2008; revision accepted 6 July 2008.
168Increased circulating levels of CRP have been associated
with prevalent and progressive knee and hip OA19e23 and
hand OA24,25, although it was pointed out that blood CRP
levels also are inﬂuenced by race, sex, body mass index
(BMI), and co-morbidities26. It has been proposed that sys-
temic inﬂammation, possibly in combination with diabetes or
insulin resistance, could increase the damage of the carti-
lage and impair the reparative processes15. Low-grade sys-
temic inﬂammation could thus be an etiological link between
obesity and OA, with a possible contribution of locally pro-
duced factors produced by adipose tissue27. Obesity and
the MetS could also be associated with OA through athero-
geneic effects of the metabolic factors, resulting in micro-
vascular changes in the subchondral bone14.
The purpose of this study was to explore whether CRP or
the components of the MetS are associated with severe OA
deﬁned as arthroplasty due to knee or hip OA, and whether
this is independent of BMI.Methods
The Malmo¨ Diet and Cancer (MDC) study is a population-based cohort
established between 1991 and 1996 (n¼ 28,466). The overall participation
rate was approximately 41%. Characteristics of all participants and non-par-
ticipants have been reported28. The study cohort was representative of the
underlying population with respect to the prevalence of, e.g., overweight
169Osteoarthritis and Cartilage Vol. 17, No. 2and smoking, while the mortality rate was higher in non-participants28. A ran-
dom 50% of those who entered the MDC cohort between November 1991
and February 1994, and who were born between 1926 and 1945
(n¼ 12,445), were invited to take part in a study on the epidemiology of ca-
rotid artery disease29 (Fig. 1). Age range was 46e68 years (mean 57.5, stan-
dard deviation [SD] 5.9). A total of 6103 participants were recruited for the
ultrasound examination. In order to arrange for blood sampling under stan-
dardized conditions, these individuals were rescheduled for a second visit
that took place a mean of 8 months later. Of the 6103 participants, 557
(9.3%) did not return for blood sampling. Another 352 individuals were ex-
cluded because of incomplete data for CRP or variables deﬁning the
MetS. Individuals with history of surgery for knee or hip OA (n¼ 23 and
n¼ 30, respectively) were excluded. After all exclusions, 5171 participants
remained for the analysis of knee OA and 5164 for the analysis of hip OA.
The Ethics Committee at Lund University approved the project.LIFESTYLE HABITSAssessment of smoking habits and leisure time physical activity has been
described29,30. In short, smoking was categorized into nonsmokers (i.e.,
never smokers and ex-smokers) and current smokers (i.e., occasional and
regular smokers). Information about smoking was missing for 114 (2.2%)
of the participants. Physical activity was assessed by 18 questions about
physical activities in different seasons. The activities were added up to
a score, based on the intensity and time spent on each activity. The score
was categorized into sex-speciﬁc quartiles when used in the analysis30.PHYSICAL EXAMINATIONBlood pressure (mmHg) was measured once in supine position after
10 min of rest. Weight (kg) and height (m) were measured with the partici-
pants wearing light indoor clothing and without shoes. The waist circumfer-
ence (cm) was measured at the level of the umbilicus.LABORATORY ANALYSESAfter an overnight fast, blood samples were drawn for the determination of
serum lipids and whole blood glucose. Samples were analyzed by standard
methods at the Department of Clinical Chemistry, Malmo¨ University Hospital.
Blood glucose was determined by a routine hexokinase method. Triglycer-
ides and total cholesterol were determined on a DAX 48 automatic analyser
with use of reagents and calibrators from the supplier of the instrumentMalmö Diet and Cancer cohort (n=28466)
Screening: February 1991 to Sept 1996 
Source population for the cardiovascular cohort:
Participants examined between Nov 1991 and Feb
1994.  n=12445  
Random 50% scheduled for
cardiovascular examinations
n=6103 
Participants:
n=5546
Non-participants
n=557
Incomplete data on
CRP or MetS, n=352 
Complete data of CRP and
MetS: n=5194 
Study population:
incidence of knee OA: n=5171
incidence of hip OA: n=5164 
History of knee OA
(n=23) or hip OA (n=30) 
Fig. 1. Flow chart of the study population.(Bayer AB, Go¨teborg, Sweden). High-density lipoprotein (HDL) cholesterol
was determined by the same procedure as used for total cholesterol but after
precipitation of low-density lipoprotein (LDL) and very low-density lipoprotein
(VLDL) with dextran sulfate31. CRP was analyzed with high-sensitive
methods in frozen plasma gathered at the baseline examination. Tina-quant
CRP latex high-sensitivity assay (Roche Diagnostics, Basel, Switzerland)
was used on an ADVIA 1650 Chemistry System (Bayer Healthcare, Tarry-
town, NY, USA). CRP was categorized into low (<1 mg/L), intermediate
(1e3 mg/L) and high levels (3 mg/L)32.DEFINITIONS OF THE MetSThe NCEPeATPIII deﬁnition was used17. The MetS is deﬁned as pres-
ence of any three components out of ﬁve, i.e., high waist circumference
(102/88 cm for men/women), low HDL (<1.03/1.29 mmol/L for men/women
or lipid-lowering medication), hypertension (130/85 mmHg or treatment for
hypertension), hyperglycemia (fasting plasma glucose 5.6 mmol/L) and hy-
pertriglyceridemia (1.7 mmol/L or treatment).DEFINITION OF KNEE AND HIP OAKnee OA was deﬁned as a ﬁrst knee arthroplasty or high tibial osteotomy
(procedures coded 8424, 8423, 8428, 8010, 8199 or NGB09, NGB19,
NGB29, NGB39, NGB49, NGB99 and NGK59)33, in combination with a diag-
nosis of OA (715 or M17 according to ICD-9 and ICD-10, respectively). Only
the ﬁrst event was counted for patients with more than one knee arthroplasty.
Hip OA was deﬁned as a ﬁrst hip arthroplasty (procedures coded 8414,
8010, NFB09, NFB19, NFB29, NFB39, NFB49 and NFB99) in combination
with a diagnosis of hip OA (715 or M16 according to ICD-9 and ICD-10, re-
spectively). Patients with more than one hip arthroplasty were only counted
once. Cases speciﬁcally coded as primary OA constituted 97% and 89% of
all knees and hips included, respectively.
The follow-up times were calculated separately for knee and hip OA. All
participants were followed until the ﬁrst OA surgery, emigration from Sweden,
death or December 31, 2005, whichever came ﬁrst. Information on knee and
hip arthroplasty for OA and mortality were based on record linkage with the
Swedish Hospital Discharge Register and the Swedish Causes of Death Reg-
ister. Individuals who moved out of Sweden were censored at the day of
emigration.STATISTICAL METHODSOne-way analysis of variance (ANOVA) and Pearsons’ c2 were used to
compare the occurrence of risk factors in individuals with and without knee
or hip OA during the follow-up period. Cox proportional hazards model
was used to explore the relationships between MetS or categories of CRP,
respectively, and incidence of knee or hip OA, and to adjust these relation-
ships for confounding factors. Age and BMI were modeled as continuous var-
iables and the quartiles of physical activity were modeled as an ordinal
variable. Sex and the components of MetS were modeled as dichotomous
variables. Three categories of CRP were used in the multivariate analysis.
Tolerance was calculated in order to estimate the degree of collinearity be-
tween the independent variables. Tolerance values below 0.20 have been
suggested to indicate collinearity problems34. P-values< 0.05 were consid-
ered statistically signiﬁcant.ResultsKNEE OADuring the mean follow-up of 12.4 years, 89 participants
(30 men and 59 women) had arthroplasty (n¼ 80) or high
tibial osteotomy (n¼ 9) due to knee OA. Waist circumfer-
ence, BMI and age were higher in participants who subse-
quently had knee OA, and prevalence of hyperglycemia
was higher (Table I). In women, a signiﬁcant relationship
was observed between the categories of CRP and subse-
quent knee OA. In men, BMI was the only risk factor with
signiﬁcant differences between those with and without
knee OA during the follow-up.HIP OAA total of 120 participants (40 men and 80 women) had
hip arthroplasty during the follow-up. Age, BMI and waist
circumference were higher in all cases and in female cases
170 G. Engstro¨m et al.: CRP, metabolic syndrome and OA(Table II). Although not signiﬁcantly, female cases with hip
OA had higher baseline CRP levels compared to controls.
Only age showed a statistically signiﬁcant difference be-
tween cases and controls in men.MULTIVARIATE ANALYSISThe relationship between CRP, MetS and incidence of
knee and hip OA is presented in Table III, with adjustments
in three models. The MetS was associated with increased
incidence of knee OA after adjustments for age and sex
(RR: 2.29, 95% CI: 1.5e3.5) and in the age-adjusted anal-
ysis of women (RR: 2.90, 95% CI: 1.7e4.9). These relation-
ships remained signiﬁcant after adjustments for smoking,
physical activity and CRP. However, after adjustments for
BMI at baseline, the relationship between MetS and inci-
dence of knee OA was attenuated and non-signiﬁcant. Of
the risk factors in Model 3, only age (RR per year: 1.07,
95% CI: 1.03e1.12) and BMI (RR per 1 kg/m2: 1.18, 95%
CI: 1.12e1.23) were signiﬁcantly associated with knee
OA. Tolerance in Model 3 was 0.73 for BMI, 0.79 for
MetS and above 0.87 for all other variables.
Age (RR per year: 1.09, 95% CI: 1.05e1.12) and BMI
(RR per 1 kg/m2: 1.08, 95% CI: 1.03e1.14) were signiﬁ-
cantly associated with incidence of hip OA in the ﬁnal model
(Model 3). Neither MetS nor CRP was associated with hip
OA in the multivariate analysis (Table III).INDIVIDUAL COMPONENTS OF THE MetSThe components of theMetSwere individually adjusted for
confounding factors in the multivariate analysis (Table IV).
Except for waist, none of the MetS components were associ-
ated with knee OA in the ﬁnal model. However, both high
waist circumference (RR: 2.16, 95% CI: 1.2e4.0,
P¼ 0.014) and BMI (RR per 1 kg/m2: 1.13, 95% CI:
1.06e1.20, P< 0.001) were independently associated with
incidence of knee OA after adjustments for other risk factors
(Table IV, Model 3). Tolerance of this regression model was
0.53 for BMI, 0.58 for waist and above 0.86 for all other risk
factors, indicating an acceptable degree of collinearity.
Except for waist (RR: 1.8, 95% CI: 1.2e2.7), none of the
individual MetS components were associated withTable
Distribution of risk factors at baseline in participants w
Knee OA All
Yes No
N 89 5082
Age (year) 59.7 5.3y 57.6 6.0 5
BMI (kg/m2) 28.9 4.6z 25.7 3.9 2
Smokers (%) 18.4 22.3
MetS (%) 39.3z 21.9
Waist (102/88 cm) (%) 44.9z 15.2
Low HDL (%) 31.5 30.8
Hypertriglyceridemia (%) 28.1 22.1
Hypertension (%) 88.8 79.9
Hyperglycemia (%) 29.2y 15.9
CRP
Geometric mean (mg/L) 1.62 1.40
<1 mg/L (%) 29.2 37.2
1e3 mg/L (%) 44.9 39.9
>3 mg/L (%) 25.8 22.9
Age and BMI are presented as meanSD. Other risk factors are pres
knee OA yes vs no and xP¼ 0.078.incidence of hip OA after adjustment for age and sex. After
adjustments for age, sex, smoking, physical activity and
CRP, high waist circumference (RR: 1.7, 95% CI:
1.1e2.6) was still associated with hip OA. This relationship
was not signiﬁcant after further adjustments for BMI (RR for
high waist: 1.1, 95% CI: 0.6e2.0, P¼ 0.693).Discussion
Relationships between obesity and OA in the knee or hip
have been reported from many studies. It has been pro-
posed that metabolic risk factors and systemic low-grade in-
ﬂammation, which often is increased in obesity, could
contribute to this relationship13e15. This prospective popula-
tion-based study conﬁrmed that high BMI or waist circum-
ference is associated with incidence of severe knee or hip
OA deﬁned as the combination of diagnosis of knee or hip
OA with arthroplasty. In the univariate analysis, women
who developed severe knee OA had higher prevalence of
the MetS, hypertension, hyperglycemia and high CRP
(>3 mg/L) than women without OA during follow-up. How-
ever, these relationships were attenuated and non-signiﬁ-
cant when BMI was taken into account in the multivariate
analysis.
Several studies have reported relationships between
CRP and various features of OA. CRP was shown to be as-
sociated with the extent and severity of knee OA, knee pain
or markers of local synovial inﬂammation, and with knee OA
progression19e23,35,36. In contrast, our results suggest that
the increased incidence of OA in individuals with elevated
CRP is largely explained by increased body mass. The ad-
ipose tissue is an important source of various proinﬂamma-
tory cytokines, which could stimulate the hepatic production
of CRP and other acute phase proteins37,38. Obesity is an
important determinant of high CRP levels39.
Our results suggest that systemic inﬂammation per se is
of little importance for incidence of OA, at least in presence
of overweight or obesity. We cannot exclude a role for local
inﬂammation associated with excess adipose tissue in the
joint. In the present study, blood for the high-sensitive
CRP assay was sampled several years before OA surgery.
It is possible that CRP better reﬂects occurrence and pro-
gression of OA in patients with established disease, thanI
ith and without severe knee OA during follow-up
Men Women
Yes No Yes No
30 2115 59 2967
9.5 5.0 57.7 6.0 59.9 5.5y 57.5 5.9
8.2 4.1z 26.2 3.5 29.3 4.7z 26.4 4.1
28.6 23.0 13.6 21.7
36.7 28.1 40.7z 17.5
30.0 17.4 52.5z 13.7
23.3 31.3 35.6 30.5
30.0 29.5 27.1 16.9
86.7 85.2 89.8* 76.1
33.3 22.0 27.1z 11.5
1.35 1.42 1.77x 1.39
43.3 35.8 22.0 38.2
36.7 41.0 49.2 39.1
20.0 23.2 28.8* 22.7
ented as proportions (%). *P< 0.050, yP< 0.010, zP< 0.001 for
Table II
Distribution of risk factors at baseline in participants with and without severe hip OA during follow-up
Hip OA All Men Women
Yes No Yes No Yes No
N 120 5044 40 2100 80 2944
Age (year) 60.0 5.1z 57.5 6.0 59.9 5.1* 57.7 6.0 60.0 5.1z 57.5 5.9
BMI (kg/m2) 27.1 4.2z 25.8 3.9 26.7 3.3 26.2 3.5 27.3 4.7z 25.4 4.1
Smokers (%) 20.3 22.2 15.0 23.3 23.1 21.4
MetS (%) 22.5 22.2 25.0 28.2 21.3 18.0
Waist (102/88 cm) (%) 25.0y 15.6 22.5 17.5 26.3y 14.2
Low HDL (%) 25.8 31.0 20.0 31.4 28.8 30.7
Hypertriglyceridemia (%) 20.0 22.2 25.0 29.4 17.5 17.1
Hypertension (%) 86.7 79.9 92.5 85.0 83.8 76.2
Hyperglycemia (%) 13.3 16.2 12.5 22.4 13.8 11.8
CRP
Geometric mean (mg/L) 1.64 1.40 1.47 1.42 1.73** 1.38
<1 mg/L (%) 29.2 37.3 32.5 36.0 27.5 38.1
1e3 mg/L (%) 45.8 39.9 47.5 40.8 45.0 39.2
>3 mg/L (%) 25.0 22.9 20.0 23.1 27.5x 22.7
Age and BMI are presented as meanSD. Other risk factors are presented as proportions (%). *P< 0.050, yP< 0.010, zP< 0.001 for hip
OA yes vs no and **P¼ 0.060, xP¼ 0.074.
171Osteoarthritis and Cartilage Vol. 17, No. 2the risk of developing OA in a population-based setting. El-
evated CRP has been associated with prevalence of radio-
logically conﬁrmed21 or symptomatic OA20,24,25, degree of
symptoms35,36 and progression of disease in participants
with OA22. In support of the present results, a population-
based study reported that the relationships between radio-
graphically determined knee and hip OA and CRP were
greatly attenuated and non-signiﬁcant after adjustmentsTable I
Multivariate analysis of CRP and MetS in relatio
Age and sex*
Knee OA
All
MetS (yes vs no) 2.3 (1.5e3.5)
CRP (1e3 vs <1 mg/L) 1.4 (0.8e2.2)
CRP (3 vs <1 mg/L) 1.4 (0.8e2.4)
Men
MetS (yes vs no) 1.5 (0.7e3.1)
CRP (1e3 vs <1 mg/L) 0.7 (0.3e1.5)
CRP (3 vs <1 mg/L) 0.7 (0.3e1.8)
Women
MetS (yes vs no) 2.9 (1.7e4.9)
CRP (1e3 vs <1 mg/L) 2.1 (1.1e4.0)
CRP (3 vs <1 mg/L) 2.1 (1.03e4.4)
Hip OA
All
MetS (yes vs no) 1.0 (0.6e1.5)
CRP (1e3 vs <1 mg/L) 1.4 (0.9e2.2)
CRP (3 vs <1 mg/L) 1.4 (0.8e2.3)
Men
MetS (yes vs no) 0.8 (0.4e1.7)
CRP (1e3 vs <1 mg/L) 1.2 (0.6e2.5)
CRP (3 vs <1 mg/L) 0.9 (0.4e2.2)
Women
MetS (yes vs no) 1.1 (0.6e1.9)
CRP (1e3 vs <1 mg/L) 1.5 (0.9e2.5)
CRP (3 vs <1 mg/L) 1.6 (0.9e2.9)
*Model 1: MetS and CRP individually adjusted for age and sex when ap
ical activity, MetS. Model 3: Model 2þBMI at the baseline examination.
Data are presented as relative risks (95% CI) for individuals with thefor BMI26. To our knowledge, there are no previous studies
of CRP and incidence of knee or hip OA in apparently
healthy individuals.
A strong correlation or collinearity between BMI and MetS
or CRP could cause problems in separating the effects of
these risk factors in the multivariate models. However, the
relationships between BMI and the other risk factors were
not strong enough to produce this problem. We calculatedII
n to incidence of severe knee and hip OA
Model 2 Model 3
2.1 (1.3e3.3) 1.1 (0.7e1.8)
1.2 (0.7e2.0) 0.9 (0.5e1.5)
1.2 (0.6e2.1) 0.7 (0.4e1.2)
1.4 (0.6e3.1) 0.6 (0.2e1.5)
0.5 (0.2e1.2) 0.4 (0.2e0.9)
0.6 (0.2e1.6) 0.4 (0.1e1.1)
2.5 (1.5e4.4) 1.4 (0.8e2.6)
1.8 (0.9e3.5) 1.4 (0.7e2.7)
1.6 (0.7e3.3) 0.9 (0.4e1.9)
1.0 (0.6e1.5) 0.7 (0.4e1.2)
1.4 (0.9e2.2) 1.3 (0.8e2.0)
1.4 (0.8e2.3) 1.1 (0.6e1.9)
0.9 (0.4e1.8) 0.7 (0.3e1.6)
1.4 (0.7e2.9) 1.3 (0.6e2.7)
1.2 (0.5e3.1) 1.1 (0.4e2.8)
1.0 (0.6e1.7) 0.7 (0.4e1.3)
1.5 (0.9e2.6) 1.3 (0.8e2.3)
1.5 (0.8e2.8) 1.1 (0.6e2.2)
propriate. Model 2: age, sex (all participants), smoking, CRP, phys-
risk factor.
Table IV
Multivariate analysis of components of the MetS in relation to incidence of severe knee and hip OA
Age and sex* Model 2 Model 3
Knee OA
Waist (102/88 cm) (%) 4.5 (3.0e6.8) 4.7 (3.0e7.4) 2.2 (1.2e4.0)
Low HDL (%) 1.0 (0.6e1.6) 0.9 (0.6e1.5) 0.7 (0.4e1.1)
Hypertriglyceridemia (%) 1.4 (0.9e2.2) 1.3 (0.8e2.1) 0.9 (0.5e1.5)
Hypertension (%) 1.7 (0.9e3.4) 1.6 (0.8e3.2) 1.3 (0.6e2.5)
Hyperglycemia (%) 2.3 (1.5e3.7) 2.2 (1.4e3.6) 1.4 (0.9e2.4)
Hip OA
Waist (102/88 cm) (%) 1.8 (1.2e2.7) 1.7 (1.1e2.6) 1.1 (0.6e2.0)
Low HDL (%) 0.8 (0.5e1.1) 0.7 (0.5e1.1) 0.7 (0.4e1.0)
Hypertriglyceridemia (%) 0.9 (0.6e1.4) 0.9 (0.5e1.4) 0.7 (0.5e1.2)
Hypertension (%) 1.4 (0.8e2.4) 1.4 (0.8e2.4) 1.3 (0.7e2.2)
Hyperglycemia (%) 0.8 (0.5e1.4) 0.8 (0.5e1.4) 0.7 (0.4e1.2)
Model 2: adjusted for age, sex, smoking, physical activity and CRP (<1 mg/L, 1e3 mg/L and 3 mg/L). Model 3: þBMI at the baseline
examination.
*Relative risks of knee OA (95% CI) for individuals with the risk factor, adjusted for age and sex.
172 G. Engstro¨m et al.: CRP, metabolic syndrome and OAthe tolerance values for the multivariate models to deter-
mine the degree of collinearity between the independent
variables. When all covariates were entered into the ﬁnal
model (Model 3), tolerance for MetS was still 0.79, which
means that 79% of the variance of MetS was unique for
that variable and only 21% could be explained by all other
independent variables. It was suggested that tolerance
values below 0.20 should be regarded as potential collin-
earity problems34. Hence, BMI is not so closely linked to
the MetS that one might expect.
The components of the MetS are well-known atheroscle-
rotic risk factors. Diabetes, which is an important comorbid
condition of the MetS, is associated with arteriosclerosis in
the large and small arteries. Prevalence of atherosclerotic
risk factors is high in individuals with OA18, and it has
been proposed that vascular pathology of subchondral
small vessels could play an etiological role in the develop-
ment of OA. This hypothesis was not supported by the pres-
ent results. It is also noteworthy that smoking, which is
strongly associated with atherosclerosis and endothelial
dysfunction40, also was unrelated to the incidence of severe
OA when BMI was taken into account. Our results are par-
tially concordant with the population-based study by Daha-
ghin et al.41, who did not ﬁnd any independent relationship
between hypertension or blood lipids and hand OA.
The participants of this cohort were almost exclusively
Caucasian, and much of the relationships between MetS
and cardiovascular disease (CVD) are based on studies
from Asian or Afro-American populations42. However, it
was shown that CRP and themetabolic risk factors are asso-
ciated with CVD also in the present Caucasian cohort43. We
cannot rule out that absence of signiﬁcant ﬁndings could be
explained by limited statistical power in the present study.
Total arthroplasty or high tibial osteotomy of the knee or
arthroplasty of the hip due to OA was used to deﬁne OA
in the present study. Other studies have used different
OA deﬁnitions, e.g., knee or hip arthroplasty without a con-
ﬁrmed diagnosis, radiographic criteria, symptom criteria, or
OA deﬁned by self-reported diagnosis. The relationship be-
tween these different OA deﬁnitions is uncertain, and their
relationship with inﬂammation and cardiovascular risk fac-
tors may not be the same. While the deﬁnition of arthro-
plasty or osteotomy due to OA will only identify a minority
of the very large OA population, it has the advantage of
an unambiguous connection with disease burden of OA
and being available in reliable national registries.The Swedish hospital discharge register was used for
case-retrieval. This register covers all Swedish hospitals.
A validation study estimated that this register includes at
least 95% of all primary knee and hip arthroplasties and
that the diagnostic misclassiﬁcation was about 5% for hip
replacements44. Primary OA was the diagnosis for more
than 85% of all primary knee arthroplasties and more than
75% of all primary hip arthroplasties in Sweden during the
follow-up period. We therefore believe that the bias in the
present study due to misclassiﬁcation of OA is small, and
likely nondifferential.
The decision to surgically treat a patient with OA is inﬂu-
enced by other factors than the severity of symptoms and
radiographic signs45. Of particular relevance to studies us-
ing arthroplasty as an outcome is the possibility of a healthy
patient selection bias in the decision to perform an arthro-
plasty. Obesity is associated with cardiovascular disease,
which hypothetically could reduce the probability of arthro-
plasty. On the other hand, obesity could be associated
with worse symptoms, which could increase the probability
of being selected for surgery. We have previously observed
that the relationships between measures of overweight and
arthroplasty for OA remain following exclusion of partici-
pants with self-reported signiﬁcant co-morbidities at the
baseline examination12. This would argue against a healthy
patient selection bias inﬂuencing our results. However, the
presence and effects of such patient selection bias are
very difﬁcult to explore and we cannot completely rule it out.
Weconclude that the increased incidenceof kneeOA inpar-
ticipantswith theMetS ismainly explainedby increasedBMI in
these individuals. In this prospective population-based study,
CRP was not associated with incidence of knee or hip OA
when possible confounding factors were taken into account.
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